Nath Bio-Genes (I) (NATHBIOGEN.NS) Stock Price

Nath Bio-Genes (I) Price

CLOSED
131.88
​
Market closed

Over the last 14 years Nath Bio-Genes (I) grew revenue by 9.6% annually, reaching 4.45 B INR. Earnings per share have grown at 10.0% per year over the last 14 years. For Nath Bio-Genes (I), the net margin of 9.4% is up versus -24.2% a few years ago. At today's price the dividend yield works out to roughly 1.52%. The payout ratio is around 14% of earnings.

Nath Bio-Genes (I) stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nath Bio-Genes (I) business model & stock analysis

Nath Bio-Genes (India) Ltd. engages in the production and marketing of seeds. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2014-01-28. The firm is engaged in the Seed Cultivation segment. The Company’s products categories include oilseeds and fiber, field crops, vegetables and plant nutrition. Its fiber and oils seeds include cotton and mustard. The firm's vegetable crop range includes chili, okra, tomato, bottle gourd, bitter gourd, cucumber, coriander, pumpkin, tinda and others. Its field corps include corn, jowar, hybrid paddy, research paddy and wheat. Its plant nutrition products include WINPro GOLii, WINall and Win Chin Win. Its forage products include NUTRIMAX and NUTRIMAX GOLD. The firm has seed processing facilities processing plants located in Maharashtra, Telangana and Andhra Pradesh. The firm also has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis.

Frequently asked questions about Nath Bio-Genes (I)

7 analysts currently rate the Nath Bio-Genes (I) stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Nath Bio-Genes (I) share trades at 1.24 EUR (131.88 INR).

The revenue of Nath Bio-Genes (I) is 4.45 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Nath Bio-Genes (I) is 416.30 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Nath Bio-Genes (I) is currently 6.02. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nath Bio-Genes (I) stock.

The price-to-sales ratio (P/S) of Nath Bio-Genes (I) is currently 0.56. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nath Bio-Genes (I) stock.

The Eulerpool Quality Score for Nath Bio-Genes (I) is 4/10.

The ISIN of Nath Bio-Genes (I) is INE448G01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Nath Bio-Genes (I) is NATHBIOGEN.NS. The ticker symbol is used to trade Nath Bio-Genes (I) shares on the stock exchange.

Fair ValueTerminal
123.97 INR
Over-/UndervaluationTerminal
Fairly valued
Industry
Food Products
Number of shares
Employees
Revenue per Employee
9.63 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Jan 28, 2014
ISIN
INE448G01010
Cusip
Y6S00H102
Market capitalization
2.51 B INRMid Cap
52-Week Range
PEG
0.90
P/E ratio
P/Ee 2027
5.07
P/Ee 2028
4.90
P/Ee 2029
4.42
P/Ee 2030
3.92
P/S
P/Se
1.04
EV/EBIT
6.46
P/B Ratio
0.37
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.08 %
Dividend
Dividend yield
1.52 %
Est. Dividend Yield
1.52 %
Payout Ratio
13.87 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
5 years
Dividend not reduced since
1 year
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Nov 2, 2026, 8:26 PM

Nath Bio-Genes (I) Peer Group

Nath Bio-Genes (I) FIGI

NBGL:IN · BBG001BN0VX9NBGL:IB · BBG005XNKKD0NBGL:IS · BBG005XNKKG7NBGL:IG · BBG005XNKKH6